LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
31 hedge funds and large institutions have $38.1M invested in LYRA THERAPEUTICS INC in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
800% more call options, than puts
Call options by funds: $9K | Put options by funds: $1K
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.01% less ownership
Funds ownership: 1.2% → 1.19% (-0.01%)
11% less funds holding
Funds holding: 35 → 31 (-4)
36% less capital invested
Capital invested by funds: $59.9M → $38.1M (-$21.8M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$144K |
| 2 |
Squarepoint
New York
|
+$28K |
| 3 |
Renaissance Technologies
New York
|
+$26.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$397K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$123K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$43K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42.6K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$11.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
26
Worth Asset Management
Dallas,
Texas
| $1.31K | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
S
28
SignatureFD
Atlanta,
Georgia
| $1K | – | – | – |
|
29
US Bancorp
Minneapolis,
Minnesota
| $1K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $229 | – | – | – |
|
|
AFM
31
Anson Funds Management
Dallas,
Texas
| – | -$123K | -783 | Closed |
|
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$42.6K | -272 | Closed |
|
|
BAM
33
Belpointe Asset Management
Reno,
Nevada
| – | -$11.6K | -74 | Closed |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -10 | Closed |
|
35
Fidelity Investments
Boston,
Massachusetts
| – | -$1.41K | -9 | Closed |
|
|
IRC
36
Investors Research Corp
Atlanta,
Georgia
| – | -$47 | – | – |
|
37
Morgan Stanley
New York
| – | -$3 | – | – |
|
LYRA Hedge Fund Activity: Q1 2023 in Review
31 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2023, worth a combined $38.1M — down 36% from $59.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LYRA and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $144K. The largest seller was Pura Vida Investments, cutting an estimated $397K.
- 31 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q1 2023, down from 35 in Q4 2022.
- Funds reported $38.1M of LYRA THERAPEUTICS INC stock for Q1 2023, down 36% quarter-over-quarter.
- 2 funds opened new LYRA THERAPEUTICS INC positions in Q1 2023 and 5 closed out, a net change of -3 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q1 2023 was Millennium Management, an estimated $144K added.
- The largest LYRA THERAPEUTICS INC seller in Q1 2023 was Pura Vida Investments, an estimated $397K sold.
Based on aggregated 13F filings for Q1 2023.